| Sources | Names Used |
|---|---|
| CTRPv2 | ML334 diastereomer |
| PharmacoGx | ML334 diastereomer |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | DUSP3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | LARP1B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | SPPL3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | SERPINF2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | INPP5F | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | NPL | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | POPDC3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | SYK | CTRPv2 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | CCDC120 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
